[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2602679B1 - Nouvelles compositions pharmaceutiques renfermant comme principe actif regulateur du mouvement des ions calcium un fragment du glucagon, et preparation d'un tel fragment - Google Patents

Nouvelles compositions pharmaceutiques renfermant comme principe actif regulateur du mouvement des ions calcium un fragment du glucagon, et preparation d'un tel fragment

Info

Publication number
FR2602679B1
FR2602679B1 FR8611769A FR8611769A FR2602679B1 FR 2602679 B1 FR2602679 B1 FR 2602679B1 FR 8611769 A FR8611769 A FR 8611769A FR 8611769 A FR8611769 A FR 8611769A FR 2602679 B1 FR2602679 B1 FR 2602679B1
Authority
FR
France
Prior art keywords
fragment
preparation
active ingredient
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8611769A
Other languages
English (en)
Other versions
FR2602679A1 (fr
Inventor
Dominique Pierre Henr Bataille
Ariane Mallat
Michel Paul Dufour
Catherine Pavoine
Sophie Lotersztajn
Francoise Pecker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to FR8611769A priority Critical patent/FR2602679B1/fr
Priority to PCT/FR1987/000317 priority patent/WO1988001174A1/fr
Publication of FR2602679A1 publication Critical patent/FR2602679A1/fr
Application granted granted Critical
Publication of FR2602679B1 publication Critical patent/FR2602679B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR8611769A 1986-08-14 1986-08-14 Nouvelles compositions pharmaceutiques renfermant comme principe actif regulateur du mouvement des ions calcium un fragment du glucagon, et preparation d'un tel fragment Expired FR2602679B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR8611769A FR2602679B1 (fr) 1986-08-14 1986-08-14 Nouvelles compositions pharmaceutiques renfermant comme principe actif regulateur du mouvement des ions calcium un fragment du glucagon, et preparation d'un tel fragment
PCT/FR1987/000317 WO1988001174A1 (fr) 1986-08-14 1987-08-12 Un fragment de glucagon regulateur du mouvement des ions calcium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8611769A FR2602679B1 (fr) 1986-08-14 1986-08-14 Nouvelles compositions pharmaceutiques renfermant comme principe actif regulateur du mouvement des ions calcium un fragment du glucagon, et preparation d'un tel fragment

Publications (2)

Publication Number Publication Date
FR2602679A1 FR2602679A1 (fr) 1988-02-19
FR2602679B1 true FR2602679B1 (fr) 1989-02-24

Family

ID=9338322

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8611769A Expired FR2602679B1 (fr) 1986-08-14 1986-08-14 Nouvelles compositions pharmaceutiques renfermant comme principe actif regulateur du mouvement des ions calcium un fragment du glucagon, et preparation d'un tel fragment

Country Status (2)

Country Link
FR (1) FR2602679B1 (fr)
WO (1) WO1988001174A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003292685A1 (en) * 2003-01-10 2004-08-10 Niigata Tlo Corporation Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene theraphy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2158123A1 (de) * 1970-12-02 1972-06-08 Ciba-Geigy Ag, Basel (Schweiz) Neue pharmazeutische Präparate
US4206199A (en) * 1977-07-22 1980-06-03 Takeda Chemical Industries, Ltd. Novel glucagon fragment and its derivatives

Also Published As

Publication number Publication date
WO1988001174A1 (fr) 1988-02-25
FR2602679A1 (fr) 1988-02-19

Similar Documents

Publication Publication Date Title
DE2967573D1 (en) Use of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridin-3-beta-methoxy ethylester-5-isopropylester for the preparation of cerebrally active drugs
IL60937A0 (en) Opitcally active 1,4-dihydropyridine compounds,their production and pharmaceutical compositions containing them
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
IL75986A (en) 3-(2-dimethylamino)ethyl)-n-methyl-1h-indole-5-methanesulphonamide,its preparation and pharmaceutical compositions containing it
GR3006177T3 (fr)
ES485540A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas, congrupos ester funcionalizados
IL87080A (en) 4-amino-5-halo 2,n-disubstituted benzamides,their preparation and pharmaceutical compositions containing them
IT8221278A0 (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
JPS56154417A (en) Use of 3,3'-azobis -(6-hydroxybenzoic acid) as drug and pharmaceutical composition containing it
NZ220950A (en) 1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and pharmaceutical compositions containing such compounds
FR2602679B1 (fr) Nouvelles compositions pharmaceutiques renfermant comme principe actif regulateur du mouvement des ions calcium un fragment du glucagon, et preparation d'un tel fragment
GB2201676B (en) Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it
DK116386A (da) Polyprenylforbindelser, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
EP0209843A3 (fr) Composés de benzylpipérazine, sa préparation, composition pharmaceutique et utilisation
ES8403487A1 (es) "procedimiento para la preparacion de n-(2-metoxietil)-noroximorfona".
HUT46364A (en) Process for producing 1,12-dihydroxy-1,6,12,13-tetraaza-dicyclodocosane-2,5,13,16-tetron and pharmaceutical compositions comprising this compound as active ingredient
IL62509A (en) Monohydrated n,n'-bis-(3-picolyl)-4-methoxy-isophthalamide,its preparation and pharmaceutical compositions containing it
IL82726A (en) Pharmaceutical compositions comprising anticonvulsively active 1-phenalkylimidazole-4-and/or-5-carboxamides and certain novel phenalkylimidazoles and their manufacture
FR2567402B1 (fr) Nouvelles compositions pharmaceutiques et cosmetiques contenant comme ingredient actif la dihydroxy-1,8 phenyl-10 anthrone-9, et procede de preparation de l'ingredient actif
IL63217A (en) N-(1-allyl-2-pyrrolidinyl-methyl)2-methoxy-4-amino-5-methylsulfamoyl benzamide,its preparation and pharmaceutical compositions containing it
FR2567756B1 (fr) Nouvelles compositions pharmaceutiques contenant comme ingredient actif l'acetyl-10 triacetoxy-1,8,9 anthracene
DE69221905D1 (de) Wismutsubsalicylat in form einer einheitsdosis
FR2532847B1 (fr) Composition pharmaceutique comprenant a titre de principe actif le 3,7,11,15-tetramethylhexadeca-1-ene-3-ol
IT1184139B (it) Composti ad attivita' mucolitica e broncodilatatrice,procedimento per la loro preparazione e composizioni farmaceutiche che licontengono come principi attivi
IT8622051A0 (it) Composizioni farmaceutiche adattivita' cicatrizzante.

Legal Events

Date Code Title Description
ST Notification of lapse